Class information for:
Level 1: CARDIOTOXICITY//DEXRAZOXANE//DOXORUBICIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
541 3252 40.0 68%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1052 9585 CARDIOTOXICITY//ANTHRACYCLINES//DOXORUBICIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CARDIOTOXICITY Author keyword 253 35% 18% 599
2 DEXRAZOXANE Author keyword 96 64% 3% 94
3 DOXORUBICIN Author keyword 84 12% 20% 663
4 ANTHRACYCLINES Author keyword 76 27% 8% 247
5 ANTHRACYCLINE Author keyword 53 25% 6% 182
6 ANTHRACYCLINE CARDIOTOXICITY Author keyword 50 84% 1% 27
7 ADRIAMYCIN Author keyword 28 14% 6% 180
8 ICRF 187 Author keyword 25 66% 1% 23
9 DOXORUBICIN CARDIOTOXICITY Author keyword 23 86% 0% 12
10 ADR 529 Author keyword 15 88% 0% 7

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CARDIOTOXICITY 253 35% 18% 599 Search CARDIOTOXICITY Search CARDIOTOXICITY
2 DEXRAZOXANE 96 64% 3% 94 Search DEXRAZOXANE Search DEXRAZOXANE
3 DOXORUBICIN 84 12% 20% 663 Search DOXORUBICIN Search DOXORUBICIN
4 ANTHRACYCLINES 76 27% 8% 247 Search ANTHRACYCLINES Search ANTHRACYCLINES
5 ANTHRACYCLINE 53 25% 6% 182 Search ANTHRACYCLINE Search ANTHRACYCLINE
6 ANTHRACYCLINE CARDIOTOXICITY 50 84% 1% 27 Search ANTHRACYCLINE+CARDIOTOXICITY Search ANTHRACYCLINE+CARDIOTOXICITY
7 ADRIAMYCIN 28 14% 6% 180 Search ADRIAMYCIN Search ADRIAMYCIN
8 ICRF 187 25 66% 1% 23 Search ICRF+187 Search ICRF+187
9 DOXORUBICIN CARDIOTOXICITY 23 86% 0% 12 Search DOXORUBICIN+CARDIOTOXICITY Search DOXORUBICIN+CARDIOTOXICITY
10 ADR 529 15 88% 0% 7 Search ADR+529 Search ADR+529

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DOXORUBICIN CARDIOTOXICITY 165 64% 5% 160
2 INDUCED CARDIOMYOPATHY 152 46% 8% 245
3 INDUCED CARDIOTOXICITY 151 44% 8% 264
4 ANTHRACYCLINE INDUCED CARDIOTOXICITY 144 64% 4% 141
5 ADRIAMYCIN CARDIOTOXICITY 141 73% 3% 108
6 ANTHRACYCLINE CARDIOTOXICITY 110 58% 4% 125
7 DOXORUBICIN THERAPY 110 63% 3% 111
8 CARDIOTOXICITY 104 21% 13% 434
9 ADRIAMYCIN INDUCED CARDIOMYOPATHY 95 67% 3% 85
10 CARDIAC TOXICITY 89 41% 5% 171

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Doxorubicin-induced cardiomyopathy 1998 845 35 74%
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies 2012 119 149 72%
Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy 2014 29 195 68%
Use of Myocardial Strain Imaging by Echocardiography for the Early Detection of Cardiotoxicity in Patients During and After Cancer Chemotherapy 2014 27 56 63%
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron 2009 204 138 85%
Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection 2013 38 273 78%
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management 2007 239 157 59%
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity 2004 1257 337 28%
Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis 2013 32 54 78%
Anthracycline cardiotoxicity: From bench to bedside 2008 151 88 67%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ROCKY MT CANC REHABIL 14 55% 0.6% 18
2 MED BIOL UNIT 4 44% 0.2% 7
3 CIR DRUG SCI 3 50% 0.1% 4
4 PL PHARMACOL HFD910 3 60% 0.1% 3
5 LATE EFFECTS OUTPATIENT CLIN 2 67% 0.1% 2
6 MOL CELLULAR PROT METAB 2 67% 0.1% 2
7 UNIT 427 2 67% 0.1% 2
8 CARDIONCOL UNIT 2 50% 0.1% 3
9 HOLTZ CHILDRENS HOSP 2 15% 0.4% 13
10 WORLDWIDE TOXICOL 2 43% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000132554 MODIFIED ANTIBIOT//IDARUBICINOL//IDARUBICIN
2 0.0000098369 GENITAL GVHD//CARDIAC LATE EFFECTS//HCT HEMATOPOIETIC CELL TRANSPLANTATION
3 0.0000094762 ERYTHROID GENES//THERMOBIOL//ACLARUBICIN
4 0.0000086986 VASCULAR TOXICITY//INTERNAL MED PERIOPERAT ASSESSMENT//BOLUS 5 FLUOROURACIL
5 0.0000071624 AN 9//SABARUBICIN//AN 7
6 0.0000070580 METHOXYMORPHOLINO DOXORUBICIN//AD 198//METHOXYMORPHOLINYL DOXORUBICIN
7 0.0000068366 MENOGARIL//ACLARUBICIN//BIOSYNTHESIS AND PROCESSING
8 0.0000065773 PIROXANTRONE//MITOXANTRONE//PIXANTRONE
9 0.0000057161 GLUTATHIONE DOXORUBICIN CONJUGATE//RAT HEPATOMA CELL//SIMULTANEOUS IMMOBILIZATION
10 0.0000053051 PROBIMANE//BIMOLANE//BISDIOXOPIPERAZINE COMPOUNDS